Children last in line for COVID-19 vaccine, lack clinical trial representation

Children have yet to be involved in any clinical trials for a COVID-19 vaccine, meaning they may have to wait significantly longer than the rest of the population to be inoculated, according to Business Insider.

The drugmakers developing the vaccine candidates now in the final stage of clinical testing — Pfizer, Moderna, AstraZeneca and Johnson & Johnson — all told Business Insider they plan to test their vaccines in children, but none gave an estimated timeline of when a vaccine could become available for children.

Moderna shared its plans to begin a pediatric trial with Business Insider, saying it hopes to get one underway by the end of 2020, pending regulatory approval.

"Right now I'm pretty worried that we won't have a vaccine available for kids by the start of next school year," Evan Anderson, MD, an Atlanta pediatrician, told The New York Times.

More articles on pharmacy:
Novartis sells $2.1B in bonds to increase access to its drugs in disadvantaged countries
FDA proposes change to rule on off-label drug use
Gilead settles kickback allegations for $97M

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers